Xiaoyu Xia Selected Research

Consciousness Disorders

1/2022	EEG Evidence Reveals Zolpidem-Related Alterations and Prognostic Value in Disorders of Consciousness.
1/2022	Long-term functional prognosis and related factors of spinal cord stimulation in patients with disorders of consciousness.
7/2020	Spinal cord stimulation modulates complexity of neural activities in patients with disorders of consciousness.
12/2019	Transcranial magnetic stimulation-evoked connectivity reveals modulation effects of repetitive transcranial magnetic stimulation on patients with disorders of consciousness.
11/2019	High-definition transcranial direct current stimulation modulates neural activities in patients with prolonged disorders of consciousness.
1/2019	Effects of Long-Lasting High-Definition Transcranial Direct Current Stimulation in Chronic Disorders of Consciousness: A Pilot Study.
8/2018	Current Status of Neuromodulatory Therapies for Disorders of Consciousness.
7/2018	Fronto-parietal coherence response to tDCS modulation in patients with disorders of consciousness.
1/2018	Long-Range Temporal Correlations of Patients in Minimally Conscious State Modulated by Spinal Cord Stimulation.
1/2018	Influence of inter-stimulus interval of spinal cord stimulation in patients with disorders of consciousness: A preliminary functional near-infrared spectroscopy study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyu Xia Research Topics

Disease

16	Consciousness Disorders 01/2022 - 01/2016
5	Persistent Vegetative State (Vegetative State) 07/2018 - 01/2016
3	Coma (Comas) 01/2019 - 01/2016
2	Neoplasms (Cancer) 02/2022 - 02/2015
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Tetanus 02/2021 - 01/2020
1	Poisoning 01/2022
1	Iron Deficiencies 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hydrocephalus (Hydrocephaly) 08/2021
1	Diphtheria 02/2021
1	Whooping Cough (Pertussis) 02/2021
1	Infections 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	COVID-19 01/2021
1	Lupus Nephritis 10/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Weight Gain 10/2019
1	Fatty Liver 10/2019
1	Leukemia 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 05/2011

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 02/2021 - 01/2020
2	Therapeutic UsesIBA 01/2022 - 01/2017
2	GlucansIBA 01/2022 - 01/2021
1	ApoferritinsIBA 02/2022
1	ethyleneIBA 02/2022
1	ferritin receptorIBA 02/2022
1	Biological ProductsIBA 02/2022
1	MethacrylatesIBA 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	IonsIBA 01/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	IronIBA 01/2022
1	InflammasomesIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	ToxoidsIBA 02/2021
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 02/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 01/2021
1	AutoantibodiesIBA 10/2020
1	Tetanus ToxinIBA 01/2020
1	CopperIBA 10/2019
1	tetraethylpyrazine (TEP)IBA 01/2016
1	KinesinsIBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 05/2011

Therapy/Procedure

7	Spinal Cord Stimulation 01/2022 - 01/2017
4	Transcranial Magnetic Stimulation 12/2019 - 01/2016
4	Transcranial Direct Current Stimulation 11/2019 - 01/2017
2	Therapeutics 01/2019 - 08/2018
1	Ventriculoperitoneal Shunt 08/2021
1	Electrodes (Electrode) 07/2018